| 000 | 01874 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250516042945.0 | ||
| 264 | 0 | _c20111013 | |
| 008 | 201110s 0 0 eng d | ||
| 022 | _a1528-0012 | ||
| 024 | 7 |
_a10.1053/j.gastro.2011.05.005 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBrown, Philip M | |
| 245 | 0 | 0 |
_aThe tryptophan hydroxylase inhibitor LX1031 shows clinical benefit in patients with nonconstipating irritable bowel syndrome. _h[electronic resource] |
| 260 |
_bGastroenterology _cAug 2011 |
||
| 300 |
_a507-16 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAbdominal Pain _xetiology |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aBiomarkers _xurine |
| 650 | 0 | 4 |
_aBiphenyl Compounds _xadministration & dosage |
| 650 | 0 | 4 | _aConstipation |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFeces |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxyindoleacetic Acid _xurine |
| 650 | 0 | 4 |
_aIrritable Bowel Syndrome _xcomplications |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPain Measurement |
| 650 | 0 | 4 |
_aPhenylalanine _xadministration & dosage |
| 650 | 0 | 4 |
_aSerotonin _xbiosynthesis |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 |
_aTryptophan Hydroxylase _xantagonists & inhibitors |
| 700 | 1 | _aDrossman, Douglas A | |
| 700 | 1 | _aWood, Alastair J J | |
| 700 | 1 | _aCline, Gary A | |
| 700 | 1 | _aFrazier, Kenny S | |
| 700 | 1 | _aJackson, Jessica I | |
| 700 | 1 | _aBronner, Johanna | |
| 700 | 1 | _aFreiman, Joel | |
| 700 | 1 | _aZambrowicz, Brian | |
| 700 | 1 | _aSands, Arthur | |
| 700 | 1 | _aGershon, Michael D | |
| 773 | 0 |
_tGastroenterology _gvol. 141 _gno. 2 _gp. 507-16 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1053/j.gastro.2011.05.005 _zAvailable from publisher's website |
| 999 |
_c20938760 _d20938760 |
||